Prevalence and predictors of default from tuberculosis treatment in Hong Kong by Chan-Yeung, MMW et al.
Title Prevalence and predictors of default from tuberculosis treatmentin Hong Kong
Author(s) Chan-Yeung, MMW; Noertjojo, K; Leung, CC; Chan, SL; Tam, CM
Citation Hong Kong Medical Journal, 2003, v. 9 n. 4, p. 263-268
Issued Date 2003
URL http://hdl.handle.net/10722/45132
Rights Creative Commons: Attribution 3.0 Hong Kong License
Hong Kong Med J Vol 9 No 4 August 2003      263
ORIGINAL ARTICLE
Key words:
Hong Kong;
Treatment refusal;
Tuberculosis
 !
 
 !"#$
 
Prevalence and predictors of default
from tuberculosis treatment in Hong
Kong
Objective. To determine the prevalence and risk factors of default from
tuberculosis treatment in Hong Kong.
Design. Retrospective study.
Setting. Data were obtained from programme forms completed by physicians in
the Hong Kong Government Tuberculosis and Chest Service and from medical
records from Hong Kong chest clinics.
Patients. In all, 5917 patients registered for antituberculous drug therapy in 1996;
medical records of 5757 patients were reviewed.
Main outcome measures. Patients who defaulted treatment were defined as those
who had failed to collect medication for more than 2 consecutive months after
the date of the last attendance during the course of treatment. Demographic and
clinical characteristics, including history, treatment, and outcome, were compared
between defaulters and non-defaulters, both among the whole group and among
those with pulmonary disease.
Results. There were 442 (8%) patients who defaulted from treatment. Forty-five
percent of those who defaulted did so in the first 2 months of treatment. Key risk
factors associated with non-compliance were a history of default, male sex, and
a history of concomitant liver disease or lung cancer. Among patients with
pulmonary tuberculosis (381 defaulters and 1537 non-defaulters), multiple drug
resistance was also associated with default from treatment. Among defaulters
with pulmonary disease, 39% were still bacteriologically positive at the time of
default.
Conclusion. Default from treatment may be partially responsible for the persistent
high rates of tuberculosis in Hong Kong in the past decade. Health professionals
should ensure that all barriers to treatment be removed and that incentives be
used to encourage treatment compliance.
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Introduction
Tuberculosis is a leading cause of morbidity and mortality
worldwide.1 In Hong Kong, the incidence of tuber-
culosis was very high in late 1940s, at nearly 700.0 cases
per 100 000 population. With the effective control
programme of the Government Tuberculosis and Chest
Service of the Hong Kong Special Administrative Region
(Chest Service) and the progressive improvement in the
socio-economic situation, the notification rate of tuber-
culosis decreased to 100.9 per 100 000 in 1995. Since then,
the incidence of tuberculosis has increased progressively—
to 101.0 in 1996, 109.0 in 1997, and 113.7 per 100 000 in
2000.2 Although the rise in incidence may merely reflect
the increased awareness among the medical profession of
the importance of notification,3 the increase may also be
real. Furthermore, the lack of a decline in the notification
rate during the past 10 years has to be explained.
Poor case management, often because of non-adherence
to treatment, has emerged as the most important factor in
the resurgence of tuberculosis and the appearance of multiple
drug resistance (MDR).4 The prolonged duration of treatment,
the need for multiple drugs, and socio-economic factors are
the main reasons for non-adherence to treatment. The cur-
rently recommended minimum duration of treatment is 6
months, which, although much shorter than the previously
recommended 12 to 24 months, is still very long. According
to the World Health Organization (WHO), directly observed
therapy (DOT) ensures successful treatment of patients with
tuberculosis. Hong Kong has used DOT since the 1970s and
was then one of the few places in the world to have such
practice.5 There are still patients who are not compliant to
DOT and default from treatment. In this study, we assessed
the prevalence and predictors of default from tuberculosis
treatment in Hong Kong.
Methods
We studied all patients who were registered for tuberculosis
treatment between 1 January 1996 and 31 December 1996
with the Chest Service, which treats about 80% to 90% of
all notified cases in Hong Kong each year. To examine the
predictors of default from treatment, we used a nested case-
control study design. Default was defined as failure to collect
medication for more than 2 consecutive months after the
date of the last attendance. For each case of default, four
controls were randomly selected (using computer-generated
random numbers) from cases of completed treatment.
Data of patients treated by the Chest Service were
obtained from programme forms that were submitted by
physicians of the Chest Service at the onset of tuberculosis
treatment and at 6, 9, and 24 months thereafter. The forms
had the following information: patient name, starting date
of treatment, age, sex, history of treatment, the type of
tuberculosis (pulmonary or extrapulmonary), the extent of
disease (if pulmonary), and the case category (new, relapse,
treatment after default, and treatment after failure). The
forms also listed the type of drug regimen used, the frequency
of drug treatment, side-effects, bacteriological status before
treatment and at 2 and 5 or 6 months from the start of
treatment, drug sensitivity of micro-organisms, and the
treatment outcome. The following information was not
available: socio-economic status, history of drug misuse,
and human immunodeficiency virus (HIV) status. In
addition, we reviewed medical records at local chest clinics
for patients with missing forms, missing information, and
inconsistent information between forms. Altogether, 5757
records were reviewed. The definitions used in this study
were modified from those according to the International
Union Against Tuberculosis and Lung Diseases (Box).6
Data were entered into an Epi-Info database (Windows
version 6.0; Centers for Disease Control and Prevention,
Atlanta, US) and their accuracy was checked. The data were
then analysed using the Statistical Package for the Social
Sciences (Windows version 6.0; SPSS Inc., Chicago, US).
The differences in clinical features between the cases of
default and the controls were tested by Chi squared analysis
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or analysis of variance. Multiple logistic regression was used
to analyse the association between various risk factors and
treatment default. This study was approved by the Ethics
Committee of the University of Hong Kong.
Results
Of the 5757 patients who were treated by the Chest Service
for tuberculosis in 1996, 442 (8%) refused treatment or failed
to attend the clinic for more than 2 consecutive months,
thereby fulfilling the criteria for treatment default.
Approximately 45% of patients who defaulted did so within
the first 2 months of treatment.
Of the 442 patients who defaulted, 381 (86%) had
pulmonary tuberculosis. Of those with pulmonary disease,
149 (39%) were still bacteriologically positive (51 smear-
and culture-positive, 86 culture-positive only, and 12 smear-
positive only) at the time of default (Table 1).
From patients who completed treatment, 1768 were
randomly selected as controls. The default group had more
men than women and a higher proportion with a history of
default compared with the control group (Table 2). There
was no significant difference in age between defaulters and
non-defaulters. Although a similar proportion of cases and
of controls had concomitant illnesses, the proportion with
diabetes was lower and the proportion with liver disease or
lung cancer was higher among those who defaulted from
treatment.
Among the controls, 1537 (87%) had pulmonary disease.
The differences between defaulters and non-defaulters
among patients with pulmonary disease were similar to the
overall differences between defaulters and non-defaulters
among the whole group in terms of distribution in age, sex,
case category, and presence of concomitant illnesses (not
shown). There were no differences between cases and
controls with pulmonary disease in the extent of disease or
presence of cavitation, and similar proportions had positive
bacteriology (Table 3). Whereas the proportion with resist-
ance to one or more drugs was similar between cases and
controls, the proportion with MDR (defined as those with
resistance to at least isoniazid and rifampicin) was higher
among cases than among controls. All seven patients with
MDR who defaulted were still culture-positive and three of
them were also smear-positive at the time of default.
Multiple logistic regression analyses were performed to
determine the risk factors associated with default among all
patients and among those with pulmonary disease only. For
the whole group, important risk factors associated with
default included male sex (odds ratio [OR]=1.5; 95% con-
fidence interval [CI], 1.1-2.1), a history of default (OR=8.2;
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Table 1. Time of default and bacteriological status of patients with pulmonary tuberculosis*
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Table 2. Characteristics of defaulters and non-defaulters*
* Data shown are No. of patients (%) unless otherwise stated
† Chi squared test
‡ NS  not significant
†
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51 (13.4)
5 (5.8)
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10 (11.6)
86 (22.6)
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>
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95% CI, 4.7-14.3), liver disease (OR=3.8; 95% CI, 1.5-9.5),
and lung cancer (OR=8.1; 95% CI, 2.5-26.3) [Table 4]. A
history of diabetes mellitus was associated with a reduced
likelihood of default (OR=0.6; 95% CI, 0.3-0.9). For patients
with pulmonary disease, in addition to the above risk factors,
MDR tuberculosis was associated with default (OR=9.4;
95% CI, 2.1-41.8).
Discussion
The Chest Service’s policy is to treat all cases of tuberculosis
with DOT. There are 18 chest clinics in Hong Kong, and
patients are allowed to move freely between them for
convenience. The clinics are open from 8:00 am to 7:30 pm
during weekdays and for half-days on Saturdays. The cost
of drug treatment is not an issue in Hong Kong, because all
antituberculous drugs are free of charge. Thus, the infra-
structure for DOT in Hong Kong is very good. Nevertheless,
442 (8%) of patients who registered at the Chest Service for
treatment of tuberculosis in 1996 defaulted from treat-
ment. Of the 381 who had pulmonary disease at the time of
default, 40% had positive results to smear or culture tests,
indicating that they were still potentially infectious. How-
ever, the treatment completion rate in Hong Kong in 1996
was about 80% at 12 months and 85% at 24 months,7 which
reaches the target set by the WHO for treatment completion.8
According to published studies, one smear- and culture-
oitarsddO lavretniecnedifnoC%59 eulavP
sesacllA
xeS
elamefsusrevelaM
)sraey(egA
yrogetacesaC
sesacwensusrevespaleR
sesacwensusrevtluafedsuoiverP
ssenllitnatimocnoC
onsusrevsey:recnacgnuL
onsusrevsey:esaesidreviL
onsusrevsey:setebaiD
esaesidyranomluP
xeS
elamefsusrevelaM
)sraey(egA
noitativaC
onsusrevseY
yrogetacesaC
esacwensusrevespaleR
esacwensusrevtluafedsuoiverP
esaesidfotnetxE
laminimsusrevetaredoM
laminimsusrevdecnavdA
ssenllitnatimocnoC
onsusrevsey:recnacgnuL
onsusrevsey:esaesidreviL
onsusrevsey:setebaiD
ytilibitpecsusgurD
evitisnesyllufsusrevecnatsisergurdelpitluM
4.1
99.0
9.0
9.8
7.5
4.4
5.0
5.1
99.0
1.1
9.0
2.8
9.0
7.0
1.8
8.3
6.0
4.9
20.0
SN
SN
100.0<
200.0
100.0<
10.0
800.0
SN
SN
SN
100.0<
SN
SN
100.0<
400.0
30.0
300.0
Table 4. Odds ratios from multiple logistic regression analysis examining the association between selected risk factors and
treatment default*
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Table 3. Extent of disease, cavitation, bacteriology, and drug susceptibility pattern among defaulters and non-defaulters with
pulmonary disease
*  Chi squared test
†  NS  not significant
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positive patient with pulmonary tuberculosis infects, on
average, about 12 others each year, and while each culture-
positive patient infects two others.9 Hence, the patients who
defaulted from treatment in 1996 might have infected 1032
individuals in the first year after default from treatment.
Furthermore, about 10% to 15% of infected individuals
develop the disease after infection and half of them may be
infectious and in turn can transmit the disease to others.10
Thus, because the rate of default from treatment has
varied by 7% to 8% each year during the past decade in Hong
Kong,11 these defaulters might have added substantially to
the pool of infectious people.
Because of other factors, such as death, natural remission,
retreatment of some cases, and the effect of partial treatment
on the viability of the bacilli, it is not possible to delineate
exactly the impact of default from treatment to the overall
rate of tuberculosis in Hong Kong. We also found that con-
comitant lung cancer was also a predictor of defaulting from
treatment. The high mortality of lung cancer may have
shortened the period of infectivity. Because the mean dura-
tion of infectivity of each case of tuberculosis is estimated
to be 2 years,12 the additional annual risk of infection attribu-
table to patients who defaulted from treatment in Hong Kong
is about 0.03%. Default from treatment is unlikely to be
solely responsible for the current stagnant rate of tuberculosis
at a relatively high level. Other factors, such as the high rate
of tuberculosis among the elderly, together with the ageing
population in Hong Kong, are probably also important.13
In this study, we found that a history of default from
treatment is the strongest predictor of non-compliance,
followed by the presence of concomitant lung cancer, liver
disease, and male sex. Thus, a history of default should alert
the health professional to give special attention to ensure
removal of all barriers to treatment. Most published studies
have shown that HIV infection, homelessness, smoking,
alcohol and drug misuse, psychiatric illness, and poverty
are all risk factors for non-compliance to treatment.14,15 In
our study, data on alcohol and drug abuse, HIV status, and
socio-economic status were not available in the programme
forms of the Chest Service. Additionally, patients with lung
cancer and liver disease might have been hospitalised or
died, but such information was not available to us.
Among patients with pulmonary disease, the risk of
MDR tuberculosis was significantly higher among de-
faulters than non-defaulters, which is consistent with most
of the published results.14,15 This finding is especially
worrisome, because all patients were still bacteriologically
positive at the time of treatment default. However, the
surveillance of antituberculous drug resistance in Hong Kong
between 1986 and 1999 showed a significant decline in
overall drug resistance.16 Multiple drug resistance decreased
from 2.7% to 1.0% for new cases and from 15.9% to 8.3%
for retreated cases.
Legal sanction against defaulters has been attempted,
but only mainly in the United Stated in the mid-1980s, when
there was a dramatic rise in the rate of tuberculosis and MDR
tuberculosis among HIV-infected individuals.17 Although
there was widespread support for such legal action, there
were concerns that these powers might be abused for use as
a means of social control, and many believed that it was
unfair to detain patients when their ability to comply with
treatment was affected by the lack of housing, primary health
care, and services for substance users.17,18 In the United
Kingdom, legislation allows for the detention of an
individual with a notifiable disease that is a threat to others,
but this legislation is rarely used.19 The moral issues in the
use of coercion and detainment in dealing with non-
adherence in the diagnosis and treatment of tuberculosis have
been widely debated.19-21 Although coercion and detainment
have been found by ethicists to be a morally acceptable
strategy to fight the spread of tuberculosis, their use to
support strategies that improve treatment compliance must
be sensitive to national and cultural differences and not
simply be based on perceived successes elsewhere. Due
regard must be paid to the possibility that such negative
measures may aggravate the social stigma and discrimination
that still surround this important airborne disease. Even if
we can achieve 100% case-holding, the strategy will still
not work unless patients come forward for treatment in the
first place.
On the other hand, it has been shown that successful
DOT programmes with a high rate of treatment completion
(86%-97%) are those that provide incentives such as shelter
for the homeless, methadone and rehabilitation pro-
grammes for drug abusers, food coupons, and money for
transportation; some programmes also provide educational
opportunities, while others make use of occupation settings
to administer the drugs.22-28 Directly observed therapy
programmes without such incentives are less successful, with
treatment completion rate of 85.0% to 87.5%.29,30
The current DOT programme in Hong Kong uses a
combination of incentives and enablers, which include educa-
tion for patients and their families, intermittent client-focused
regimens, money for food, referrals for other social services, as
well as use of outreach teams and the tracing of defaulters.
Greater efforts are required in the education of the patients and
public to increase their understanding of the importance of
treatment completion for patients with tuberculosis.
Conclusion
In Hong Kong, the rate of default from tuberculosis treatment
in 1996 was 8%—unchanged from the rate during the past
decade. The defaulters probably contributed to the pool of
infectious patients in the community and may be partially
responsible for the persistent high rate of tuberculosis locally.
A history of default from treatment should alert health
professionals to ensure that all barriers to treatment
be removed, and that incentives be used to encourage treat-
ment compliance.
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